GPR Intervention Research group
OtherThe research intervention consisted in the reappointment of three GPR therapeutic postures.
NCT Number: NCT03732053
This research study is developed on an experimental design with randomized controlled intervention were participated 135 subjects with AD including 45 of the control group. It lasted 6 months with pre-post tests (T0-T1) executed before and after six months of treatment. By having in focus the evaluation of GPR therapy effects on cognitive, proprioceptive, depressive, autonomy, gait and life quality of the above mentioned subjects.
Looking for future studies?
Notify Me40 year–95 year
All sexes
Interventional
Not applicable
In order to assess the cognitive abilities of the patients a cognitive test was administered which acts through a scale concerning depression and mood evaluation as well as a questionnaire was developed aiming to evaluate the examined subjects' functional abilities: Mini Mental State Examination (MMSE), Quality of Life in Alzheimer Disease (QoL-AD), geriatric Depression Scale (GDS), Barthel Index (BI), Neuropsychiatric Inventory (NPI), Tinetti Scale (TS).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The research intervention consisted in the reappointment of three GPR therapeutic postures.
Time frame: Change from baseline cognitive evaluation at 6'th month
The therapeutist provides the Mini Mental State Examination (MMSE) scale records. The evaluation consits in a 0-30 points-scale. Lower scores imply the severity of dementia.
Time frame: Change from baseline cognitive evaluation at 6'th month
The therapeutist measures in the begining and in the end of the study the quality of life in patients with Alzheimer's disease (QoL-AD). This questionnaire consists in 13 elements referring to the perception that patients have concerning various aspects of their life: mood, health, cognition, environment and functional capacity. The range of scores is 13-52, were higher scores indicate a better life quality.
Time frame: Change from baseline cognitive evaluation at 6'th month
The version of 15 articles was used, which given its length can be validly and reliably resolved by patients themselves in the quality of a self-report questionnaire aiming to investigate the possible presence of depressive symptoms.
Time frame: Change from baseline cognitive evaluation at 6'th month
This scale is used by therapist to measure the performance in the basic activities of daily life of AD patients. The maximum score used is 100 points and refers to the patient's independence in all basic daily living activities.
Time frame: Change from baseline cognitive evaluation at 6'th month
This test includes 12 symptoms scored according to the phenomenon severity and frequency. It is a helpful instrument for the therapist because of specifically designed for the assessment of psycho-behavioral disorders in individuals with cognitive impairment.
Time frame: Change from baseline cognitive evaluation at 6'th month
The therapist used the equilibrium sub-scale, which consists in 7 elements and has a score between 0 and 13. Highest scores indicate a better balance.
Universidad Católica San Antonio de Murcia
Other
The Effectiveness of Physical Rehabilitation in the Enhancement of Proprioceptive and Cognitive Aspects on Alzheimer Disease Patients
Acronym: GPR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01539031
Alzheimer Disease, Alzheimer's Type Dementia
Anjo, Aichi-ken, Japan
View Trial DetailsNCT01404169
Alzheimer Disease, Alzheimer's Type Dementia
Beijing, Beijing Municipality, China
View Trial DetailsNCT01276353
Alzheimer Disease, Alzheimer's Type Dementia
Akita, Japan
View Trial DetailsNCT01972204
Alzheimer's Type Dementia
Fujisawa, Kanagawa, Japan
View Trial Details